Cerebrospinal fluid C9 in demyelinating disease

Neurology

Volumn 36, Issue 11, 1986, Pages 1503-1506

  Compston, D ^a   Morgan, B P ^a   Oleesky, D ^a   Fifield, R ^a   Campbell, A K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C9; IMMUNOGLOBULIN G;

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; ETIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PERIPHERAL NERVOUS SYSTEM; PLASMA; PRIORITY JOURNAL;

COMPLEMENT C9; COMPLEMENT SYSTEM PROTEINS; DEMYELINATING DISEASES; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS;

EID: 0022971740     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.36.11.1503     Document Type: Article

References (24)

1. Mattson DH, Roos RP, Arnason BGW. Iso-electric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature 1980;287:335–7.
2. Paterson PY, Whitacre CC. The enigma of oligoclonal immunoglobulin G in cerebrospinal fluid from multiple sclerosis patients. Immunology Today 1981;2:111–7.
3. Morgan BP, Campbell AK, Compston DAS. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Lancet 1984;2:251–4.
4. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull 1977;33:4–8.
5. Morgan BP, Campbell AK, Luzio JP, Siddle K. Immunoradiometric assay for human complement component C9 utiliing monoclonal antibodies. Clin Chim Acta 1983;134:85–94.
6. Lefvert AK, Link H. IgG production within the central nervous system: a critical review of proposed formulae. Ann Neurol 1985;17:13–20.
7. Wekerle H, Fierz W. T cell approach to demyelinating diseases. Springer Semin Immunopathol 1985;8:97–110.
8. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984;307:273–6.
9. Traugott V, Scheinberg L, Raine CS. On the presence of Ia positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neumimmunol 1985;8:1–14.
10. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985;312:1405–11.
11. Cyong J-C, Witkin SS, Reiger B, Barbarese E, Good RA, Day NK. Antibody-independent complement activation by myelin via the classical complement pathway. J Exp Med 1982;155:587–98.
12. Silberberg DH, Manning MC, Schreiber AD. Tissue culture demyelination by normal human sera. Ann Neurol 1985;15:575–80.
13. Silverman BA, Carney DF, Johnston CA, Vanguri P, Shin ML. Isolation of membrane attack complex of complement from myelin membranes treated with serum complement. J Neurochem 1984;42:1024–9.
14. Liu WT, Vanguri P, Shin ML. Studies on demyelination in vitro: the requirement of membrane attack complex components of the complement system. J Immunol 1983;131:778–82.
15. Yam P, Petz LD, Tourtellotte WW, Ma BI. Measurement of complement components in cerebrospinal fluid by radioimmunoassay in patients with multiple sclerosis. Clin Immunol Immunopathol 1980;17:492–505.
16. Delaenerie-Laupretre N, Suet-Hubert C, Marcelli-Barge A. Cerebrospinal fluid C2 and HLA system in multiple sclerosis. Tissue Antigens 1982;19:79–84.
17. Jans H, Heltberg A, Zeeberg I, Halkjaer Kristensen J, Fog T, Raun NE. Immune complexes and the complement factor C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis. Acta Neurol Scand 1984;69:34–8.
18. Lachmann PJ, Thompson RA. Reactive lysis: the complementmediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med 1970;131:643–57.
19. Hallett MB, Luzio JP, Campbell AK. Stimulation of Ca24-dependent chemiluminescence in rat polymorphonuclear leucocytes by polystyrene beads and the non-lytic action of complement. Immunology 1981;44:569–76.
20. Campbell AK, Morgan BP. Monoclonal antibodies demonstrate protection of polymorphonuclear leucocytes against complement attack. Nature 1985;317:164–6.
21. Morgan BP, Dankert JR, Esser AF. Recovery of human neutrophils from complement attack removal of the membrane attack complex by endocytosis and exocytosis. J Immunol (in press).
22. Schlaepfer WW. Vesicular disruption of myelin stimulated by exposure of nerve to calcium ionophore. Nature 1977;265:734–6.
23. Bostock H, McDonald WI. Recovery and function after demyelination. In: Sears TA, ed. Neuronal-glial cell interrelationships. Berlin: Springer-Verlag, 1982:287–302.
24. Schauf CL, Schauf V, Davis FA, Mizen MR. Complement-dependent serum neuroelectric blocking activity in multiple sclerosis. Neurology (NY) 1978;28:426–30.